Andrés Pérez
University of Chile
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Andrés Pérez.
Revista Medica De Chile | 2002
Gittith Sánchez; Inés Zulantay; Marta Gajardo; Juan Venegas; Roxana Villanueva; Andrés Pérez; Federico Liendo; Werner Apt; Aldo Solari
Background: Cellular immune mechanisms of the resistance to infection by T cruzi as well as the pathogenesis of Chagas disease are still controversial. Aim: To quantify and analyse the peripheral blood immune cells from chagasic and non chagasic patients by flow cytometry. Patients and methods: Peripheral blood samples were taken from 21 individuals seropositive for Chagas disease, under no specific treatment. Control samples from 21 healthy blood donors were also obtained. To quantify immune cells populations by flow cytometry, antibodies against CD3, CD4, CD8, CD16/56, CD45/14, CD19 and HLA-DR markers were used. Results: The percentage of CD8+ cells was low and the CD4+/CD8+ ratio was high in chagasic patients, compared to their non infected counterparts. No statistically significant differences in the number of CD4+, NK, B, CD4+HLADR+ and CD8+HLADR+ cells, were observed within the two groups. Conclusions: These results show that Chilean chronic chagasic patients have lower percentage of CD8+ cells and higher CD4+/CD8+ ratio than non infected individuals (Rev Med Chile 2002; 130: 363-367
Revista Medica De Chile | 2012
Gilda Donoso; Elizabeth Lagos; Pía Rosati; Pilar Hevia; Karen Cuevas; Gabriel Lobo; Andrés Pérez; César Jiménez; Daniela Gutiérrez
BACKGROUND Abnormal Dimercaptosuccinic acid (DMSA) renal scintigraphy performed six months after an acute pyelonephritis (AP) is generally interpreted as scarring. AIM To perform a follow up of childhood patients showing scintigraphic renal lesions during the acute phase of pyelonephritis (within 7 days from the beginning of fever). MATERIAL AND METHODS A scintigraphic control was carried out at 5-7 months and, in case of persistent lesions, an additional late scintigraphy at 10-13 months. All patients were followed clinically for one year and those with a relapse of urinary tract infection were excluded from the study. RESULTS Eighty five patients with a median age of 8 months were included. Among these, the first scintigraphic control was normal in 59 (69%) and abnormal in 26 patients (31%). In five of these 26 patients (5/26:19%-5/85: 6%), a considerable regression of the lesions was obvious on the early control, and normalized completely on the late control. When expressing the results in kidney units, 107 showed lesions during the acute phase of infection; 69% was normal at the early control. Thirty three showed lesions persisting at the early control (31%) and 7 out of these 33 (21%) became normal on the late control (7/107: 7%). In total, 25% of the children included in the study (24% of the kidney units) remained with renal sequelae one year after the initial episode of AP. CONCLUSIONS The persistence of scintigraphic lesions six months after an episode of AP, does not necessarily correspond to permanent scars, since normalization can sometimes be observed on late controls.Background: Abnormal Dimercaptosuccinic acid (DMSA) renal scintigraphy performed six months after an acute pyelonephritis (AP) is generally interpreted as scarring. Aim: To perform a follow up of childhood patients showing scintigraphic renal lesions during the acute phase of pyelonephritis (within 7 days from the beginning of fever). Material and Methods: A scintigraphic control was carried out at 5-7 months and, in case of persistent lesions, an additional late scintigraphy at 10-13 months. All patients were followed clinically for one year and those with a relapse of urinary tract infection were excluded from the study. Results: Eighty five patients with a median age of 8 months were included. Among these, the first scintigraphic control was normal in 59 (69%) and abnormal in 26 patients (31%). In five of these 26 patients (5/26:19%-5/85: 6%), a considerable regression of the lesions was obvious on the early control, and normalized completely on the late control. When expressing the results in kidney units, 107 showed lesions during the acute phase of infection; 69% was normal at the early control. Thirty three showed lesions persisting at the early control (31%) and 7 out of these 33 (21%) became normal on the late control (7/107: 7%). In total, 25% of the children included in the study (24% of the kidney units) remained with renal sequelae one year after the initial episode of AP. Conclusions: The persistence of scintigraphic lesions six months after an episode of AP, does not necessarily correspond to permanent scars, since normalization can sometimes be observed on late controls.
Clinical Nuclear Medicine | 2013
Gilda Donoso; Cesar Paulsen; Paulina Riquelme; Gabriel Lobo; Daniela Gutiérrez; Andrés Pérez; César Jiménez
Aim The objective of this study was to evaluate the degree and incidence of bone involvement in patients with cat scratch disease. Methods Patients admitted between 2004 and 2011 at the pediatric department for cat scratch disease and a positive serology for Bartonella henselae were identified. Only those having undergone a bone scintigraphy (BS) were included in this retrospective study. Results Sixteen girls and 8 boys with a mean age of 7 years were studied. Bone scintigraphy was positive in 6 (25%), but only 2 had bone pain. Axial involvement was present in all 6 patients, and appendicular lesions in 3 of them. Three patients had a BS control, with improvement or normalization after treatment with antibiotics. Conclusions Bone involvement occurs infrequently in patients with cat scratch disease and is not always associated with specific signs. Cat scratch disease must be suspected in patients with fever of unknown origin presenting multifocal lesions on BS.
Revista latinoamericana de ciencias sociales, niñez y juventud | 2011
Claudio Gonzalo Contreras; Andrés Pérez
Rev. med. nucl. Alasbimn j | 2007
Gilda Donoso; Gabriel Lobo; Claudia Coll; Paz Arteaga; Andrés Pérez; César Jiménez; Rodrigo Bascuñan; Rodrigo Pardo
Rev. med. nucl. Alasbimn j | 2003
Gilda Donoso R.; Gabriel Lobo S.; María de la Paz Arteaga V.; Francisca Arnello V.; César Jiménez; Andrés Pérez
Revista Latinoamericana de Ciencias Sociales, Niñez y Juventud | 2011
Claudio Gonzalo Contreras; Andrés Pérez
Revista Latinoamericana de Ciencias Sociales, Niñez y Juventud | 2011
Claudio Gonzalo Contreras; Andrés Pérez
Revista Chilena de Radiología | 2003
David Ladrón de Guevara H; Gabriel Lobo; Esteban Cortés; Virginia Martinez; César Jiménez; Andrés Pérez
Rev. med. nucl. Alasbimn j | 2003
David Ladrón de Guevara; Gabriel Lobo; Humberto Dighero; Juan Ramón Soto; Freddy Valdés; Carlos Wolff; Andrés Pérez; Antonio Moreno Jiménez